Analyst Research: Abbott Laboratories (ABT.N)

ABT.N on New York Stock Exchange

43.59USD
31 Oct 2014
Price Change (% chg)

$0.10 (+0.23%)
Prev Close
$43.49
Open
$44.00
Day's High
$44.00
Day's Low
$43.44
Volume
1,915,738
Avg. Vol
1,288,553
52-wk High
$44.20
52-wk Low
$35.65

Search Stocks
Reports per page
Select Report Title Date Provider Pgs Price
Thomson Reuters Stock Report - ABBOTT LABORATORIES (ABT-N) 28 Oct 2014 Thomson Reuters Stock Report 12 25.00
ValuEngine - Toronto Quantitative Stock Report for ABT 27 Oct 2014 ValuEngine, Inc. 7 25.00
Trading Report for (ABT). A detailed report, including free correlated market analysis, and updates. 27 Oct 2014 Stock Traders Daily 12 20.00
ABT: Due Diligence Review: Forensic Earnings and Valuation 27 Oct 2014 New Constructs, LLC 9 25.00
"The Economy Matters" Report for ABT: the economy's impact on ABT's price and risk, featuring the powerful Economic Climate Rating and the new MacroRisk "Stoplight" and Risk Correspondence Score 27 Oct 2014 MacroRisk Analytics/EconomicInvestor 8 25.00
ValuEngine Rating and Forecast Report for ABT 26 Oct 2014 ValuEngine, Inc. 11 25.00
Wright Investors Service Comprehensive Report for Abbott Laboratories 26 Oct 2014 Wright Reports 56 75.00
Abbott Laboratories 25 Oct 2014 S&P Capital IQ – STARS Reports 11 127.00
Absolute Software 25 Oct 2014 S&P Capital IQ Quantitative Report 8 92.00
ABBOTT LABORATORIES (ABT) 12-months forecast 24 Oct 2014 Pechala's Reports 1 15.00
 
Name Age Since Current Position

Miles White

59 1999 Chairman of the Board, Chief Executive Officer

Thomas Freyman

59 2004 Chief Financial Officer, Executive Vice President - Finance

Hubert Allen

48 2013 Executive Vice President, General Counsel, Secretary

Stephen Fussell

56 2013 Executive Vice President - Human Resources

Richard Ashley

70 2004 Executive Vice President - Corporate Development
Search Stocks